Clinical Trial Update: Efficacy and Safety of Olmesartan Associated With Chlorthalidone Versus Benicar HCT® in Essential Hypertension Control [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing olmesartan with chlorthalidone against Benicar HCT for essential hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• BENICAR HCT (olmesartan medoxomil-hydrochlorothiazide)
• Chlorthalidone (chlorthalidone)
• OLMESARTAN MEDOXOMIL (olmesartan medoxomil)

Snippet

Sponsor: EMS | Conditions: Arterial Hypertension | Phase 3 | Status: WITHDRAWN